HBW
CVS icon

Hazlett, Burt & Watson’s CVS Health CVS Stock Holding History

Hazlett, Burt & Watson’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$131K Buy
1,835
+306
+20% +$23.6K 0.04% 305
2025
Q4 		$120K Buy
1,529
+342
+29% +$27K 0.04% 319
2025
Q3 		$89K Sell
1,187
-495
-29% -$33.9K 0.03% 330
2025
Q2 		$117K Buy
1,682
+165
+11% +$10.8K 0.05% 258
2025
Q1 		$103K Sell
1,517
-410
-21% -$24.5K 0.05% 272
2024
Q4 		$86K Sell
1,927
-648
-25% -$36.4K 0.04% 293
2024
Q3 		$163K Buy
2,575
+229
+10% +$13.4K 0.08% 225
2024
Q2 		$139K Sell
2,346
-2,401
-51% -$150K 0.07% 225
2024
Q1 		$379K Sell
4,747
-359
-7% -$27.4K 0.23% 95
2023
Q4 		$403K Sell
5,106
-683
-12% -$48.6K 0.27% 73
2023
Q3 		$403K Sell
5,789
-3,170
-35% -$225K 0.3% 69
2023
Q2 		$620K Buy
8,959
+406
+5% +$28.9K 0.46% 39
2023
Q1 		$635K Buy
8,553
+763
+10% +$64K 0.52% 34
2022
Q4 		$727K Sell
7,790
-308
-4% -$29.7K 0.64% 30
2022
Q3 		$773K Buy
8,098
+22
+0.3% +$2.18K 0.75% 26
2022
Q2 		$750K Sell
8,076
-23
-0.3% -$2.25K 0.69% 30
2022
Q1 		$819K Buy
+8,099
New +$851K 0.65% 32

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hazlett, Burt & Watson's CVS Position: Q1 2026 in Review

Hazlett, Burt & Watson increased its CVS Health (CVS) stake by 20% in Q1 2026, buying an estimated $23.6K and bringing the position to 1,835 shares worth $131K. The position accounts for 0.04% of the portfolio, ranked #305.

Hazlett, Burt & Watson first reported a position in CVS in Q1 2022 and has held it in 17 quarters since. The position peaked at $819K in Q1 2022. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Hazlett, Burt & Watson held 1,835 shares of CVS Health worth $131K as of Q1 2026.
  • Hazlett, Burt & Watson bought 306 CVS Health shares in Q1 2026, an estimated $23.6K.
  • CVS Health made up 0.04% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #305 holding.
  • Hazlett, Burt & Watson first reported a position in CVS Health in Q1 2022 and has held it in 17 quarters since.
  • Hazlett, Burt & Watson's CVS Health position peaked at $819K in Q1 2022.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.